Voxtur Clinical Research
Voxtur Clinical Research is a full-service Contract Research Organization based in Chennai, India, providing Phase II-IV clinical trials, BA/BE bioanalytical studies, NABL-accredited diagnostics, regulatory affairs and quality management services to global pharmaceutical, biotechnology, nutraceutical and cosmetic sponsors.
- Company typePrivate
- Founded2018
- HeadquartersTambaram, India
- Headcount11–50
- GTM typeB2B
- OfferingServices
What Voxtur Clinical Research does
Voxtur Clinical Research Pvt Ltd is a full-service Contract Research Organization (CRO) headquartered in a 24,000 sq.ft facility in Tambaram, Chennai, India, that delivers clinical research, bioanalytical, diagnostic, regulatory affairs, project management and quality assurance services to global Pharmaceutical, Biotechnology, Nutraceutical and Cosmetic industry sponsors. Its service catalog spans Phase II to Phase IV clinical trials, BA/BE and bioavailability studies, pharmacokinetic and pharmacodynamic testing, NABL-accredited diagnostic laboratory work (Biochemistry, Serology, Haematology, Clinical Pathology, Endocrinology and specialized assays such as Dengue and Leptospirosis, Thyroid Profile, Chromosomal Aberration and Cancer Marker tests), regulatory consultancy, computer system validation and 21 CFR Part 11 compliance support, organized around an integrated single-contract delivery model.
The technology backbone centers on a NABL-accredited diagnostic laboratory equipped with random-access biochemistry analyzers (SelectraProM, Vitros 250), chemi-luminescence immunoassay systems (Vitros ECiQ), five-part differential hematology analyzers (Sysmex 800i, XT 1800i) and bioanalytical instrumentation including multiple LC-MS/MS platforms (API 5500, API 4000, API 3200), ICP-MS, ion chromatography and GC-MS, supported by over 50,000-sample ultra-low temperature storage and a network of 200+ GCP-trained investigators across India. Specialized capabilities for BA/BE work include in-vitro dermal studies, dermal microdialysis, tape stripping, Franz diffusion cells and vasoconstrictor assays.
Revenue is generated on a project-based professional services model via direct enterprise field sales to sponsors, with each engagement scoped end-to-end and consolidated under a single contract covering third-party vendor management and local site agreements. Customer segmentation is horizontal across pharma, biotech, nutraceutical and cosmetic sponsors requiring USFDA, EMA, WHO, MHRA, NPRA, ANVISA and AFSSAPS-acceptable data, and the company's competitive narrative rests on its NIL-483 USFDA audit record, validated bioanalytical methods for 70+ molecules (including complex hormonal and endogenous compounds) and a multi-center study footprint with documented experience across oncology, dermatology, psychiatry and diabetes.
Voxtur Clinical Research firmographics
Firmographics- Name
- Voxtur Clinical Research
- Legal name
- Voxtur Clinical Research Pvt Ltd.
- Website
- https://voxturglobal.com
- Company type
- Private
- Founded year
- 2018
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Voxtur Clinical Research is a full-service Contract Research Organization based in Chennai, India, providing Phase II-IV clinical trials, BA/BE bioanalytical studies, NABL-accredited diagnostics, regulatory affairs and quality management services to global pharmaceutical, biotechnology, nutraceutical and cosmetic sponsors.
- Ownership category
- akta.pro rank
Voxtur Clinical Research industry classification
Industry- Product category
- Contract Research Services
- NAICS
- Medical Laboratories (621511), Research and Development in the Physical, Engineering, and Life Sciences (54171), Research and Development in Biotechnology (except Nanobiotechnology) (541714), Scientific Research and Development Services (5417)
- SIC
- Services-Commercial Physical & Biological Research (8731), Services-Medical Laboratories (8071), Services-Testing Laboratories (8734)
- akta.pro primary industry
- Clinical CROs (Phase I–IV) (HLAGAAAA)
- akta.pro secondary industries
- Central Laboratory & Clinical Trial Testing CROs (HLAGAAAE), Clinical Quality Assurance (GCP QA, TMF/QMS oversight) (HLAGAKAI), Specialty Therapeutic-Area CROs (e.g., oncology/rare disease) (HLAGAAAL), Clinical Data Management, Biostatistics & Statistical Programming CROs (HLAGAAAF)
Keywords
Where Voxtur Clinical Research is headquartered
LocationHeadquarters
- HQ city
- Tambaram
- HQ country
- India
- HQ region
- Asia
Offices1 record
Markets served
Voxtur Clinical Research business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Infrastructure, Technology or R&D, Operations, Marketing or Sales
Revenue model
- Clinical Research Services: Contract research services including Phase II-IV clinical trials, bioequivalence/bioavailability studies, pharmacokinetic and pharmacodynamic testing for pharmaceutical and biotechnology clients
- Diagnostic Services: Diagnostic services in Biochemistry, Serology, Haematology, Clinical Pathology and Endocrinology including specialized services like Dengue & Leptospirosis Assay, Thyroid Profile, Chromosomal Aberration Test, Cancer Marker testing
- Regulatory Affairs Services: Regulatory consultancy for clinical trials and BA/BE studies including site monitoring, document audit, GCP/GCLP compliance inspection, complete data audit for bioequivalence studies, system audits, 21 CFR 11 compliance
Go-to-market motion1 record
Distribution channels1 record
Marketing channels3 records
Voxtur Clinical Research product offering
Product offeringCore offering
Voxtur Clinical Research is a full-service Contract Research Organization (CRO) that delivers integrated clinical trial management (Phase II–IV), bioanalytical testing, NABL-accredited diagnostic services, regulatory affairs consultancy, project management, and quality management for global pharmaceutical, biotechnology, nutraceutical, and cosmetic industry sponsors. The company operates from a 24,000 sq.ft facility in Chennai, India, providing end-to-end drug development support from protocol preparation and site selection through regulatory submissions accepted by FDA, USFDA, and EMA.
Product overview
Voxtur Clinical Research is a full-service Contract Research Organization (CRO) offering an integrated portfolio of clinical research services for global Pharmaceutical, Biotechnology, Nutraceutical, and Cosmetic industries. The company provides six interconnected core service offerings: Clinical Trials (Phase II-IV studies), Diagnostics (NABL-accredited laboratory), Project Management, Regulatory Affairs, Quality Management, and Bioanalytical Services. These services are designed to work together, covering the complete drug development lifecycle from site selection and patient recruitment through regulatory submissions to final product approval.
Differentiator
Problem solved
Functional benefit
Products and services
- Clinical Trials
Quantifiable outcome
- Successfully conducted studies with NIL 483 observations in USFDA audits
- +1 more outcomes
Companies that use Voxtur Clinical Research
Customer profileSegments4 records
Ideal customer profiles2 records
Voxtur Clinical Research technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
Voxtur Clinical Research partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Luminol BiopharmasupportingVoxtur has a partnership with Luminol Biopharma located in Padifor for using advanced diagnostic instruments including Real Time PCR (Applied Biosystem-7500), Acoustic Focusing Cytometer, GC-MS, LC-MS/MS, Western Blot Imager (Spectramax i3), Multimode ELISA Reader (Biotek), Column Chromatography (GE), PCR, and UV-Spectrophotometer (Agilent Technologies).
Scale indicators5 records
Recent moves5 records
Expansion highlights5 records
Voxtur Clinical Research competitors and assessment
Company assessmentDirect peers
- GVK Biosciences: India-based CRO providing clinical research, bioanalytical, and BA/BE services. Directly comparable to Voxtur in geography, service mix, and target customer base of global pharma sponsors seeking India-based cost arbitrage.
- Lambda Therapeutic Research: India-based CRO focused on BA/BE, bioanalytical, and clinical research services for global pharma sponsors. Directly comparable to Voxtur in service mix (clinical trials + bioanalytical + regulatory) and in targeting USFDA/EMA submissions from India.
- Cliantha Research: India-based full-service CRO with clinical research, bioanalytical, and dermatology/cosmetics capabilities. Directly comparable to Voxtur in therapeutic-area specialization (dermatology, BA/BE) and global pharma client base.
- Veeda Clinical Research: India-headquartered CRO providing clinical trials, bioanalytical, and BA/BE services to global pharma and biotech. Similar scale, service portfolio, and India-based cost arbitrage model as Voxtur.
- Syngene International: India-based full-service CRO/CDMO offering clinical development, bioanalytical, and integrated research services to global pharma. Comparable to Voxtur in India delivery model, regulatory-grade infrastructure, and BA/BE study capabilities, though at significantly larger scale.
Broad incumbents
- Labcorp Drug Development (formerly Covance): Global CRO offering clinical trials, central laboratory, bioanalytical, and diagnostic services. The diagnostic laboratory component in particular is comparable to Voxtur's NABL-accredited diagnostic service, though at global scale.
- PAREXEL International: Global CRO providing clinical research, regulatory, and bioanalytical services across all major geographies. Overlaps with Voxtur's clinical and regulatory service offering but serves as a much larger established incumbent targeting the same global pharma sponsor base.
- SGS Health Sciences: Global life sciences testing and CRO services provider including clinical research and bioanalytical capabilities. Comparable to Voxtur in analytical and clinical trial services, but operates as a multinational with broader portfolio across geographies.
- PPD (Thermo Fisher Scientific): Global CRO now part of Thermo Fisher offering clinical development, laboratory, and regulatory services worldwide. Operates in the same CRO category as Voxtur but as a multinational incumbent with substantially larger infrastructure and sponsor relationships.
- IQVIA: World's largest CRO offering end-to-end clinical, bioanalytical, regulatory, and real-world evidence services. Operates as a broad incumbent in the same CRO category as Voxtur, competing for global pharma contracts but at vastly greater scale and geographic reach.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks3 records
Key highlights6 records
Customer concentration
Voxtur Clinical Research social profiles
Digital presenceVoxtur Clinical Research compliance and trust
Trust signalCompliance2 records
Voxtur Clinical Research financial estimates
Financial estimateRevenue estimate
Valuation estimate
Voxtur Clinical Research leadership team
Management profileNumber of profiles
Profiles5 records
Voxtur Clinical Research funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Voxtur Clinical Research M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Voxtur Clinical Research
What does Voxtur Clinical Research do?
Voxtur Clinical Research is a full-service Contract Research Organization (CRO) that delivers integrated clinical trial management (Phase II–IV), bioanalytical testing, NABL-accredited diagnostic services, regulatory affairs consultancy, project management, and quality management for global pharmaceutical, biotechnology, nutraceutical, and cosmetic industry sponsors. The company operates from a 24,000 sq.ft facility in Chennai, India, providing end-to-end drug development support from protocol preparation and site selection through regulatory submissions accepted by FDA, USFDA, and EMA.
Is Voxtur Clinical Research a public or private company?
Voxtur Clinical Research is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Voxtur Clinical Research founded?
Voxtur Clinical Research was founded in 2018. It employs 11 to 50 people.
Where is Voxtur Clinical Research based?
Voxtur Clinical Research is headquartered in Tambaram, India, in the Asia region.
How does Voxtur Clinical Research make money?
Three revenue lines are on record. Clinical Research Services are the primary driver. The others are diagnostic Services and regulatory Affairs Services.
Who are Voxtur Clinical Research's main competitors?
Direct peers on record are GVK Biosciences, Lambda Therapeutic Research, Cliantha Research, Veeda Clinical Research and Syngene International. Broad incumbents are Labcorp Drug Development (formerly Covance), PAREXEL International, SGS Health Sciences, PPD (Thermo Fisher Scientific) and IQVIA.
Does Voxtur Clinical Research have an API?
No public API is recorded for Voxtur Clinical Research.
What industry is Voxtur Clinical Research in?
Voxtur Clinical Research's product category is Contract Research Services. Its primary akta.pro industry code is HLAGAAAA, Clinical CROs (Phase I–IV), with a secondary code of HLAGAAAE, Central Laboratory & Clinical Trial Testing CROs. Its NAICS code is 621511 and its SIC code is 8731.